Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Revenue (2023 - 2025)

Metagenomi (MGX) has disclosed Revenue for 3 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue fell 59.32% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.2 million, a 51.79% decrease, with the full-year FY2025 number at $25.2 million, down 51.79% from a year prior.
  • Revenue was $3.9 million for Q4 2025 at Metagenomi, down from $8.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $20.0 million in Q2 2024 to a low of $3.9 million in Q4 2025.
  • A 3-year average of $10.2 million and a median of $10.4 million in 2024 define the central range for Revenue.
  • Peak YoY movement for Revenue: soared 76.48% in 2024, then crashed 63.02% in 2025.
  • Metagenomi's Revenue stood at $12.4 million in 2023, then dropped by 22.46% to $9.6 million in 2024, then crashed by 59.32% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Revenue are $3.9 million (Q4 2025), $8.7 million (Q3 2025), and $8.5 million (Q2 2025).